Education
About Us
Working with TipRanks
Follow Us
Vikram Karnani Insider Profile
4 Followers
Vikram Karnani, EVP & President, International at Horizon Therapeutics, holds 197.86K shares in Collegium Pharmaceutical (Ticker: COLL), holds 104.17K shares in Horizon Therapeutics (Ticker: HZNP), holds ― shares in Dyne Therapeutics (Ticker: DYN).
Vikram Karnani Horizon Therapeutics (HZNP)EVP & President, International
Horizon Therapeutics (HZNP)
EVP & President, International
Not Ranked
Vikram Karnani has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Vikram Karnani holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Vikram Karnani
Vikram Karnani's Trading History
Horizon Therapeutics
Feb 23, 2021
―
Uninformative Sell
728.70K
$12.11M
Collegium Pharmaceutical
Feb 12, 2026
President & CEO, Director
Uninformative Buy
―
$8.23M
Dyne Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Vikram Karnani's performance on stock
You May Also Like
Vikram Karnani insider profile FAQ
What is the percentage of profitable transactions made by Vikram Karnani?
The percentage of profitable transactions made by Vikram Karnani is ―.
What is the average return per transaction made by Vikram Karnani?
The average return per transaction made by Vikram Karnani is ―.
What stocks does Vikram Karnani hold?
Vikram Karnani holds: HZNP, COLL, DYN stocks.
What was Vikram Karnani’s latest transaction?
Vikram Karnani latest transaction was an Uninformative Buy of ―.
What was Vikram Karnani's most profitable transaction?
Vikram Karnani’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Vikram Karnani's role in Horizon Therapeutics?
Vikram Karnani's role in Horizon Therapeutics is EVP & President, International.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.